| http://www.w3.org/ns/prov#value | - The offset rail stent of claim 12, wherein the therapeutic agent is an antiproliferative agent selected from the group consisting of Paclitaxel, Rapamycin, ABT-578, Biolimus A9, Everolimus, tacrolimus, and derivatives and analogs thereof.
|
